However, little is known about the TβRII status in lung cancer and whether restoring TGF-β signalling by the introduction of functional TGF-β type II receptor alters tumorigenicity in TGF-β unresponsive lung cancer cell lines that do not express the type II receptor. The gene discussed is TGFBR2; the disease is lung carcinoma.